Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
36,3 USD | +0,11% | -4,42% | -8,47% |
Attività
Numero di dipendenti: 160
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Novel Therapeutics
100,0
%
| 2 | 100,0 % | 7 | 100,0 % | +192,02% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 2 | 100,0 % | 7 | 100,0 % | +192,02% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Tibor Keler
FOU | Founder | 65 | 01/01/83 |
Anthony Marucci
FOU | Founder | 62 | 01/01/83 |
Sam Martin
DFI | Director of Finance/CFO | 53 | 01/04/09 |
Diane Young
CTO | Chief Tech/Sci/R&D Officer | 68 | 08/07/19 |
Chief Administrative Officer | 49 | 01/08/12 | |
Freddy Jimenez
LAW | General Counsel | 55 | 01/02/16 |
General Counsel | 67 | 03/10/17 | |
Richard Wright
PRN | Corporate Officer/Principal | 60 | 01/01/12 |
Corporate Officer/Principal | 52 | 01/01/09 | |
Ronald A. Pepin
PRN | Corporate Officer/Principal | 68 | 07/07/11 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Herbert Conrad
BRD | Director/Board Member | 91 | 01/03/08 |
Cheryl L. Cohen
BRD | Director/Board Member | 58 | 16/06/22 |
Harry H. Penner
BRD | Director/Board Member | 78 | 01/01/97 |
James Marino
BRD | Director/Board Member | 74 | 08/03/17 |
Chairman | 70 | 01/05/01 | |
Anthony Marucci
FOU | Founder | 62 | 01/01/83 |
Garry Neil
BRD | Director/Board Member | 70 | 16/06/22 |
Director/Board Member | 71 | 15/06/17 | |
Rita Jain
BRD | Director/Board Member | 62 | 16/02/23 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 64 403 377 | 65 686 894 ( 101,99 %) | 0 | 101,99 % |
Coordinate società
Celldex Therapeutics, Inc.
Perryville III Building 53 Frontage Road
08827, Hampton
+908 200 7500
http://www.celldex.comSettore
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
-8,47% | 2,39 Mrd | |
+1,51% | 42,75 Mrd | |
+49,22% | 41,61 Mrd | |
+8,57% | 41,34 Mrd | |
-12,36% | 26,59 Mrd | |
+8,92% | 25,49 Mrd | |
-25,13% | 18,12 Mrd | |
+29,17% | 12,24 Mrd | |
-3,12% | 11,76 Mrd | |
+6,35% | 11 Mrd |
- Borsa valori
- Azioni
- Azione CLDX
- Società Celldex Therapeutics, Inc.